Theravance Biopharma
TBPH
TBPH
107 hedge funds and large institutions have $946M invested in Theravance Biopharma in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 32 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
107
Holders Change
-11
Holders Change %
-9.32%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
15
Increased
33
Reduced
32
Closed
26
Calls
$69K
Puts
$1K
Net Calls
+$68K
Net Calls Change
+$230K
Top Buyers
| 1 |
GPP
1
Great Point Partners
Greenwich,
Connecticut
|
$14.7M |
| 2 |
2
Wellington Management Group
Boston,
Massachusetts
|
$97.2M |
| 3 |
LCM
3
Laurion Capital Management
New York
|
$11.4M |
| 4 |
4
Morgan Stanley
New York
|
$10.5M |
| 5 |
5
BlackRock
New York
|
$79.8M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FCA
126
FinTrust Capital Advisors
Greenville,
South Carolina
| – | -$3 | -200 | Closed |
|
|
MAM
127
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -172 | Closed |
|
|
GT
128
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$1K | -73 | Closed |
|
129
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -54 | Closed |
|